SOP for Formulation Development Excipient Selection

Selecting Excipients for Formulation Development

1) Purpose

The purpose of this SOP is to outline the procedure for selecting excipients during the formulation development process, ensuring that the chosen excipients are compatible with the API and meet project and regulatory requirements.

2) Scope

This SOP applies to all formulation development projects within the organization, covering the entire excipient selection process from initial identification to final selection and documentation.

3) Responsibilities

The responsibilities for this SOP include:
Project Manager: Overseeing the excipient selection process and ensuring all criteria are met.
Team Members: Participating in the identification, evaluation, and selection of excipients.
Quality Assurance: Reviewing and approving the excipient selection documentation.

4) Procedure

4.1 Initial Identification of Excipients

Identify potential excipients based on the desired properties of the formulation.
Gather initial data on each identified excipient, including its chemical properties, functionality, and regulatory status.
Document the initial list of potential excipients and their key characteristics.

4.2 Compatibility Studies

Conduct compatibility studies to assess the interaction between the API and potential excipients.
Evaluate the stability and performance of the API-excipient combinations under various conditions.
Document the results of the compatibility studies in a compatibility assessment report.

4.3 Detailed Evaluation of Excipients

Conduct a detailed evaluation of each compatible excipient, considering factors such

as:

Functional properties (e.g., binder, filler, lubricant)
Toxicity and safety data
Regulatory compliance
Supply chain reliability

Perform comparative analyses to identify the most suitable excipients.

Document the detailed evaluation in an excipient assessment report.

4.4 Selection of the Optimal Excipients

Review the excipient assessment report with key stakeholders.
Consider stakeholder feedback and recommendations.
Select the excipients that best meet the formulation’s requirements and project objectives.
Document the selected excipients in an excipient selection report.

4.5 Approval of the Selected Excipients

Submit the excipient selection report to senior management and quality assurance for review.
Obtain formal approval from senior management and quality assurance.
Communicate the approved excipients to all team members and stakeholders.

4.6 Documentation and Record Keeping

Ensure all documentation related to the excipient selection process is complete and accurate.
Maintain records of the excipient selection report, assessment data, and approval documentation.
Store documentation in accordance with organizational record-keeping policies.

5) Abbreviations, if any

API: Active Pharmaceutical Ingredient
SOP: Standard Operating Procedure

6) Documents, if any

Compatibility Assessment Report
Excipient Assessment Report
Excipient Selection Report

7) Reference, if any

– ICH Q8: Pharmaceutical Development
– FDA Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations

8) SOP Version

Version 1.0